Back to results
US 2025/0145628 A1Published application
Pyrazolopyrimidines, compositions comprising them and uses thereof
OwnerJeremy Green, Shawn Gallagher-Duval +3inventors
InventorsJeremy Green, Shawn Gallagher-Duval, Alexandre Lemire, Yuchen Zhou, Hong Wang
Life of this patent
Estimating the term…
Abstract
The present document relates to pyrazolopyrimidine compounds, pharmaceutical compositions comprising the same and their use in the treatment or prevention of diseases and disorders associated with the cannabinoid CB1 receptor. For example, the pyrazolopyrimidine compounds, or a tautomeric form and/or salt thereof, are of Formula I: Formula I wherein R1 to R4 are as defined herein.
Claims60
A compound of Formula I:
- wherein,
- R1 and R2 are each independently selected from optionally substituted C6-10aryl and optionally substituted C5-10heteroaryl;
- R3 is selected from optionally substituted C1-12alkyl, optionally substituted C1-12alkoxy, optionally substituted alkylamino or dialkylamino, optionally substituted C3-10cycloalkyl, optionally substituted C3-10heterocycloalkyl, optionally substituted C6-10aryl, and optionally substituted C5-10heteroaryl, optionally substituted —X1—C3-10cycloalkyl, optionally substituted —X1—C3-10heterocycloalkyl, optionally substituted —X1—C6-10aryl, and optionally substituted —X1—C5-10heteroaryl;
- R4 is selected from NH2, optionally substituted C1-12alkoxy, optionally substituted alkylamino or dialkylamino, optionally substituted C3-10cycloalkyl, optionally substituted C3-10heterocycloalkyl, optionally substituted —X2—C3-10cycloalkyl, and optionally substituted —X2—C3-10heterocycloalkyl;
- X1 is selected from O and NR5, wherein R5 is H or an optionally substituted C1-6alkyl;
- and
- X2 is selected from O and NR6, wherein R6 is H or an optionally substituted C1-6alkyl;
- or an isomer and/or a tautomer thereof, or a pharmaceutically acceptable salt thereof.
5 more elements
-55. (canceled)
A compound which is selected from
Dependencies are inferred from the claim text.